John A. Tallarico

11.0k total citations · 3 hit papers
48 papers, 3.5k citations indexed

About

John A. Tallarico is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, John A. Tallarico has authored 48 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 18 papers in Organic Chemistry and 9 papers in Oncology. Recurrent topics in John A. Tallarico's work include Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (12 papers) and Chemical Synthesis and Analysis (10 papers). John A. Tallarico is often cited by papers focused on Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (12 papers) and Chemical Synthesis and Analysis (10 papers). John A. Tallarico collaborates with scholars based in United States, Switzerland and China. John A. Tallarico's co-authors include Marc L. Snapper, Markus Schirle, Jeffrey M. McKenna, Daniel K. Nomura, Scott M. Brittain, Timothy J. Mitchison, Feng Yan, Michele L. Randall, Andreas Bender and Daniel Young and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

In The Last Decade

John A. Tallarico

48 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications

2022 132 citations Nathaniel J. Henning, Jessica N. Spradlin et al. profile →
Rational Chemical Design of Molecular Glue Degraders

2023 103 citations Ethan S. Toriki, James W. Papatzimas et al. ACS Central Science profile →
Accelerating antiviral drug discovery: lessons from COVID-19

2023 98 citations Annette von Delft, Matthew D. Hall et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by John A. Tallarico

Since Specialization

Citations

This map shows the geographic impact of John A. Tallarico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Tallarico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Tallarico more than expected).

Fields of papers citing papers by John A. Tallarico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Tallarico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Tallarico. The network helps show where John A. Tallarico may publish in the future.

Co-authorship network of co-authors of John A. Tallarico

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Tallarico. A scholar is included among the top collaborators of John A. Tallarico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Tallarico. John A. Tallarico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerating antiviral drug discovery: lessons from COVID-19 breakdown → 2023 ·Nature Reviews Drug Discovery ·Annette von Delft, Matthew D. Hall, Ann D. Kwong, Lisa A. Purcell, Kumar Singh Saikatendu, Uli Schmitz, John A. Tallarico, Alpha A. Lee	98
2	Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB 2023 ·Cell chemical biology ·(unknown), Yoo Jin Cho, (unknown), Dustin Dovala, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Daniel K. Nomura	59
3	Rational Chemical Design of Molecular Glue Degraders breakdown → 2023 ·ACS Central Science ·Ethan S. Toriki, James W. Papatzimas, (unknown), Dustin Dovala, Andreas O. Frank, Matthew J. Hesse, (unknown), Jae-Geun Song, (unknown), (unknown), F. García, Scott M. Brittain, Andrew C. Kile, Lynn M. McGregor, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Daniel K. Nomura	103
4	Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function 2021 ·Cell chemical biology ·Mai Luo, Jessica N. Spradlin, Lydia Boike, Bingqi Tong, Scott M. Brittain, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Thomas J. Maimone, Daniel K. Nomura	114
5	Manumycin polyketides act as molecular glues between UBR7 and P53 2020 ·Nature Chemical Biology ·Yosuke Isobe, Mikiko Okumura, Lynn M. McGregor, Scott M. Brittain, Michael D. Jones, Xiaoyou Liang, R. Larry White, William C. Forrester, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Thomas J. Maimone, Daniel K. Nomura	91
6	Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC 2020 ·Cell chemical biology ·Lydia Boike, Alexander G. Cioffi, (unknown), (unknown), Nathaniel J. Henning, Michael D. Jones, Gang Liu, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Daniel K. Nomura	94
7	Bardoxolone conjugation enables targeted protein degradation of BRD4 2020 ·Scientific Reports ·Bingqi Tong, Mai Luo, (unknown), Jessica N. Spradlin, John A. Tallarico, Jeffrey M. McKenna, Markus Schirle, Thomas J. Maimone, Daniel K. Nomura	100
8	An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity 2020 ·Cell chemical biology ·Seth Carbonneau, Sujata Sharma, Liaomin Peng, (unknown), Dominik Hainzl, Martin Hénault, (unknown), (unknown), Janine Shulok, John A. Tallarico, Jeff Porter, Jennifer L. Brogdon, Glenn Dranoff, James E. Bradner, Marc Hild, (unknown)	31
9	Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications 2019 ·ACS Chemical Biology ·Carl C. Ward, (unknown), Scott M. Brittain, Patrick S. Lee, Clive Yik‐Sham Chung, Kenneth H. Kim, Yana Petri, Jason R. Thomas, John A. Tallarico, Jeffrey M. McKenna, Markus Schirle, Daniel K. Nomura	228
10	Harnessing the anti-cancer natural product nimbolide for targeted protein degradation 2019 ·Nature Chemical Biology ·Jessica N. Spradlin, Xirui Hu, Carl C. Ward, Scott M. Brittain, Michael D. Jones, (unknown), Milton To, Andrew Proudfoot, Elizabeth Ornelas, (unknown), James A. Olzmann, Dirksen E. Bussiere, Jason R. Thomas, John A. Tallarico, Jeffrey M. McKenna, Markus Schirle, Thomas J. Maimone, Daniel K. Nomura	294
11	Two low complexity ultra-high throughput methods to identify diverse chemically bioactive molecules using Saccharomyces cerevisiae 2017 ·Microbiological Research ·(unknown), Martin Pfeifer, Christian N. Parker, Sven Schuierer, John A. Tallarico, Dominic Hoepfner, N. Rao Movva, (unknown), Stephen B. Helliwell	6
12	Jenkins-CI, an Open-Source Continuous Integration System, as a Scientific Data and Image-Processing Platform 2016 ·SLAS DISCOVERY ·Ioannis K. Moutsatsos, Imtiaz Hossain, Claudia Agarinis, Fred Harbinski, Yann Abraham, (unknown), Xian Zhang, Christopher J. Wilson, Jeremy L. Jenkins, (unknown), John A. Tallarico, Christian N. Parker	11
13	SEC-TID: A Label-Free Method for Small-Molecule Target Identification 2014 ·SLAS DISCOVERY ·Michael Salcius, Andras J. Bauer, (unknown), Shu Li, Antonin Tutter, Jacob Raphael, Wolfgang Jahnke, Jean‐Michel Rondeau, (unknown), John A. Tallarico, Gregory A. Michaud	11
14	DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells 2014 ·Nature Chemical Biology ·Yegor D. Smurnyy, (unknown), Hua Wu, Elizabeth McWhinnie, John A. Tallarico, Yi Yang, Feng Yan	76
15	Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents 2013 ·Antimicrobial Agents and Chemotherapy ·Daryl L. Richie, Katherine V. Thompson, Christian Studer, (unknown), Thomas Aust, Ralph Riedl, David Estoppey, Jianshi Tao, Jessica A. Sexton, T. P. Zabawa, Joseph E. Drumm, Simona Cotesta, (unknown), Sven Schuierer, Nicole Hartmann, N. Rao Movva, John A. Tallarico, Neil S. Ryder, Dominic Hoepfner	35
16	Natural products reveal cancer cell dependence on oxysterol-binding proteins 2011 ·Nature Chemical Biology ·Anthony W. G. Burgett, Thomas B. Poulsen, Kittikhun Wangkanont, (unknown), (unknown), Kousei Shimada, Shuichi Okubo, Kevin C. Fortner, Yoshihiro Mimaki, Minpei Kuroda, Jason Murphy, David J. Schwalb, Eugene C. Petrella, Iván Cornella‐Taracido, Markus Schirle, John A. Tallarico, Matthew D. Shair	208
17	Kinase Inhibitor Profiling Using Chemoproteomics 2011 ·Methods in molecular biology ·Markus Schirle, Eugene C. Petrella, Scott M. Brittain, David J. Schwalb, Edmund Harrington, Iván Cornella‐Taracido, John A. Tallarico	12
18	Integrating high-content screening and ligand-target prediction to identify mechanism of action 2007 ·Nature Chemical Biology ·Daniel Young, Andreas Bender, J.D. Hoyt, Elizabeth McWhinnie, Gung‐Wei Chirn, (unknown), John A. Tallarico, Mark Labow, Jeremy L. Jenkins, Timothy J. Mitchison, Feng Yan	266
19	A Small-Molecule Inhibitor of Mps1 Blocks the Spindle-Checkpoint Response to a Lack of Tension on Mitotic Chromosomes 2005 ·Current Biology ·Russell Dorer, Sheng Zhong, John A. Tallarico, Wing Hung Wong, Timothy J. Mitchison, Andrew W. Murray	62
20	A one-bead, one-stock solution approach to chemical genetics: part 1 2001 ·Chemistry & Biology ·Helen E. Blackwell, (unknown), Robert A. Stavenger, John A. Tallarico, (unknown), Michael A. Foley, Stuart L. Schreiber	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact